OCCASIONAL PIECE
Cobalt chloride administration in athletes: a new perspective in blood doping?
1 Ist Chimica e Microscopia Clinica, Università di Verona, Verona, Italy
2 Servizio di Immunoematologia e Trasfusione, Azienda Ospedaliera di Verona
Correspondence to:
Correspondence to:
Professor Lippi
Ist Chimica e Microscopia Clinica, Università di Verona, Verona, Italy; ulippi{at}tin.it
Blood doping is an illegal and unfair way of enhancing athletic performance by increasing the oxygen carrying capacity of the blood. Currently used methods usually involve stimulation of erythropoiesis. Gene therapy targeting the hypoxia inducible factor pathway may be an attractive alternative to traditional blood doping techniques. Hypoxia activates a large number of genes with essential roles in cell and tissue adaptation to low oxygen. Cobalt chloride is a well established chemical inducer of hypoxia-like responses such as erythropoiesis. Cobalt supplementation is not banned and therefore would not be detected by current anti-doping testing. Although there is as yet no direct or anecdotal evidence of cobalt chloride administration to athletes, its use should be warned against as being not only unfair but potentially dangerous.
Keywords: blood doping; erythropoietin; laboratory testing; cobalt; hypoxia inducible factor
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
